Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 2:13:31.
doi: 10.3389/fnint.2019.00031. eCollection 2019.

Investigating Potential Biomarkers in Autism Spectrum Disorder

Carolyn Bridgemohan  1   2 , David M Cochran  3   4 , Yamini J Howe  2   5 , Katherine Pawlowski  1 , Andrew W Zimmerman  3   4 , George M Anderson  6 , Roula Choueiri  3   4 , Laura Sices  7   8 , Karen J Miller  9   10 , Monica Ultmann  9   10 , Jessica Helt  5 , Peter W Forbes  1 , Laura Farfel  7   9   11 , Stephanie J Brewster  1 , Jean A Frazier  3   4   12 , Ann M Neumeyer  2   5
Affiliations

Investigating Potential Biomarkers in Autism Spectrum Disorder

Carolyn Bridgemohan et al. Front Integr Neurosci. .

Abstract

Background: Early identification and treatment of individuals with autism spectrum disorder (ASD) improves outcomes, but specific evidence needed to individualize treatment recommendations is lacking. Biomarkers that could be routinely measured within the clinical setting could potentially transform clinical care for patients with ASD. This demonstration project employed collection of biomarker data during regular autism specialty clinical visits and explored the relationship of biomarkers with clinical ASD symptoms.

Methods: Eighty-three children with ASD, aged 5-10 years, completed a multi-site feasibility study integrating the collection of biochemical (blood serotonin, urine melatonin sulfate excretion) and clinical (head circumference, dysmorphology exam, digit ratio, cognitive and behavioral function) biomarkers during routine ASD clinic visits. Parents completed a demographic survey and the Aberrant Behavior Checklist-Community. Cognitive function was determined by record review. Data analysis utilized Wilcoxon two-sample tests and Spearman correlations.

Results: Participants were 82% male, 63% White, 19% Hispanic, with a broad range of functioning. Group means indicated hyperserotonemia. In a single regression analysis adjusting for race and median household income, higher income was associated with higher levels of blood serotonin and urine melatonin sulfate excretion levels (p = 0.004 and p = 0.04, respectively). Melatonin correlated negatively with age (p = 0.048) and reported neurologic problems (p = 0.02). Dysmorphic status correlated with higher reported stereotyped behavior (p = 0.02) and inappropriate speech (p = 0.04).

Conclusion: This demonstration project employed collection of multiple biomarkers, allowed for examination of associations between biochemical and clinical measures, and identified several findings that suggest direction for future studies. This clinical research model has promise for integrative biomarker research in individuals with complex, heterogeneous neurodevelopmental disorders such as ASD.

Keywords: ASD; autism; biomarkers; clinical research; dysmorphology; melatonin; serotonin.

PubMed Disclaimer

References

    1. Abdelrahman H. M., Sherief L. M., Alghobashy A. A., Abdel Salam S. M., Hashim H. M., Abdel Fattah N. R., et al. (2014). Association of 5-HT2A receptor gene polymorphisms with gastrointestinal disorders in Egyptian children with autistic disorder. Res. Dev. Disabil. 36C 485–490. 10.1016/j.ridd.2014.10.023 - DOI - PubMed
    1. Abdulamir H. A., Abdul-Rasheed O. F., Abdulghani E. A. (2018). Serotonin and serotonin transporter levels in autistic children. Saudi Med. J. 39 487–494. 10.15537/smj.2018.5.21751 - DOI - PMC - PubMed
    1. Aldinger K. A., Lane C. J., Veenstra-VanderWeele J., Levitt P. (2015). Patterns of risk for multiple co-occurring medical conditions replicate across distinct cohorts of children with autism spectrum disorder. Autism Res. 8 771–781. 10.1002/aur.1492 - DOI - PMC - PubMed
    1. Aman M. G., Singh N. N., Stewart A. W., Field C. J. (1985). The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am. J. Ment. Defic. 89 485–491. - PubMed
    1. American Psychiatric Association, and DSM-5 Task Force (2013). Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, DC: American Psychiatric Association.

LinkOut - more resources